n.自身抗原，自体抗原

Autoantibodies can target autoantigens, leading to autoimmune diseases in the body.
自身抗体可能会攻击自身抗原，导致身体出现自身免疫性疾病。
The identification of novel autoantigens is crucial for understanding and treating autoimmune disorders.
发现新的自身抗原对于理解和治疗自身免疫疾病至关重要。
Researchers have discovered an association between certain genetic mutations and the production of autoantibodies against specific autoantigens.
研究人员发现某些遗传突变与产生针对特定自身抗原的自身抗体有关联。
In rheumatoid arthritis, autoantigens like citrullinated peptides are recognized by the immune system as foreign, triggering an inflammatory response.
在类风湿性关节炎中，像二硫键化的肽这样的自身抗原被免疫系统识别为外来物质，从而引发炎症反应。
Autoantigenic epitopes can be modified through post-translational modifications, altering their immunogenicity.
自身抗原的表位可以通过翻译后修饰进行改变，从而影响其免疫原性。
Scientists are exploring how environmental factors might trigger the immune system to mistakenly recognize its own autoantigens.
科学家正在研究环境因素如何可能诱导免疫系统错误地识别自身的自身抗原。
In some cases, autoantibodies can form due to a malfunctioning immune system that mistakenly targets healthy cells as autoantigens.
在某些情况下，由于免疫系统功能障碍，可能会错误地将健康细胞识别为自身抗原并产生自身抗体。
Treatment for autoimmune diseases often involves suppressing the immune system's response to autoantigens to prevent further inflammation.
治疗自身免疫疾病通常涉及抑制免疫系统对自身抗原的反应以防止进一步的炎症。
The development of personalized medicine may involve identifying and targeting specific autoantigens to tailor treatment for individual patients.
个性化医疗的发展可能涉及到识别和针对特定的自身抗原来定制个体病人的治疗方案。
Understanding the complex network of autoantigens and their interactions with antibodies is a critical step in developing effective therapies for autoimmune conditions.
理解自身抗原及其与抗体的复杂网络是开发有效治疗自身免疫疾病疗法的关键一步。